News >

Secondary Cancer Risk Remains an Unresolved Issue in CLL

Jessica Hergert
Published: Wednesday, Sep 18, 2019

David Bond, MD, an assistant professor at the Ohio State University Comprehensive Cancer Center

David Bond, MD

Patients with chronic lymphocytic leukemia (CLL) have an elevated risk of second primary neoplasia (SPN); however, the role of BTK inhibitors in second cancer development remains largely unexplored, according to David Bond, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication